Dequest Z 010 en es it fr

Dequest Z 010 Brand names, Dequest Z 010 Analogs

Dequest Z 010 Brand Names Mixture

  • No information avaliable

Dequest Z 010 Chemical_Formula


Dequest Z 010 RX_link

Dequest Z 010 fda sheet

Dequest Z 010 msds (material safety sheet)

Dequest Z 010 Synthesis Reference

No information avaliable

Dequest Z 010 Molecular Weight

391.46 g/mol

Dequest Z 010 Melting Point

No information avaliable

Dequest Z 010 H2O Solubility

10 mg/L

Dequest Z 010 State


Dequest Z 010 LogP


Dequest Z 010 Dosage Forms

Tablets (100 mg)

Dequest Z 010 Indication

For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.

Dequest Z 010 Pharmacology

Flavoxate is a spasmolytic flavone derivative that acts by relaxing the smooth muscle in the urinary tract. Flavoxate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Muscarinic receptors play an important role in several major cholin-ergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion.

Dequest Z 010 Absorption

Well absorbed from gastrointestinal tract.

Dequest Z 010 side effects and Toxicity

The oral LD50 for flavoxate HCl in rats is 4273 mg/kg. The oral LD50 for flavoxate HCl in mice is 1837 mg/kg. Symptoms of overdose include convulsions, decreased ability to sweat, (warm, red skin, dry mouth, and increased body temperature), hallucinations, increased heart rate and blood pressure, and mental confusion.

Dequest Z 010 Patient Information

Dequest Z 010 Organisms Affected

Humans and other mammals